However, regarding the relationship between XPC expression and chemoresistance, conflicting results have been reported, as both enhanced resistance [131] and increased sensitivity [132] to cisplatin have been reported after XPC overexpression in CRC cells. Here, XPC is linked to colorectal carcinoma.